Advisory & Consulting Services
We bring focused, dedicated and fully aligned transaction support capabilities
Management Consulting and Operational Support
Providing guidance as you assess complex strategic alternatives, e.g., corporate strategy and capital planning, commercial growth, and cross-border initiatives.
Extension of Management Teams
Working as a functional member of your commercial and corporate transaction teams, enabling you to expand your global reach, maintain lean operations and bolster your C-level presence.
Business and Financial Analysis
Performing extensive industry, competitive and market analyses to guide corporate strategy and management decisions.
Supervision of Professional Services
Assisting with supervision and management of outside law firms, investment banks, accounting firms and other professional service providers to improve efficacy and reduce costs.
Data Room & Closing Deliverables Prep
Building and structuring data rooms and preparing supporting documentation and closing deliverables, with an aim to accelerate deal velocity and produce a positive impact on valuation.
IR, Marketing and Strategic Communications
Preparing teasers, decks, press releases and other materials tailored for specific target audiences, e.g., investors, partners, regulators, and customers.
Helping you identify, approach, negotiate with, and transact with licensees, including those in unfamiliar foreign jurisdictions
Identifying, approaching, and evaluating partners and structuring, negotiating and completing strategic partnerships, contractual JVs, and entity-based JVs.
Providing these services with respect to a broad range of corporate transactions, including mergers, acquisitions (both buy-side and sell-side ), investments, corporate restructuring, and succession planning.
Advisory Services - Licensing Case Study
OUR TYPICAL LICENSING TRANSACTIONS INCLUDE:
Milestone-based payments (e.g., on regulatory approvals) Sales-based milestones
Long-term net sales royalty streams
CASE STUDY: IGNIS THERAPEUTICS / NEUROSIGMA
Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS system in China.
NeuroSigma receives a significant upfront payment and up to $10 million of milestone payments, in addition to royalties and other compensation under the license agreement.
Advisory Services - Strategic Partnerships Case Study
TRANSACTION ADVISORY AND STRATEGIC PARTNERSHIPS
We can advise you with respect to the negotiation, structuring, documentation and execution of commercial strategic partnerships, including contractual joint ventures, entity-based joint ventures and other packaged partnership transactions.
CASE STUDY: KT CORPORATION / NEUROSIGMA
KT Corp. made a $5 million equity investment in NeuroSigma’s digital health and neuro-electronics platform.
The transaction followed the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KT.
The companies will jointly develop and commercialize ADHD and other digital therapies inside and outside of Korea.
We also assisted NeuroSigma to negotiate and complete the conversion of a substantial portion of its existing debt into equity, concurrently with the closing of KT Corp’s investment, which further strengthened NeuroSigma’s balance sheet for future growth.